Original Article

You have full text access to this OnlineOpen article

Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy†

Ten-Year Results from the French Adjuvant Study Group GETIS 02 Trial

  1. Corinne Veyret MD1,‡,*,
  2. Christelle Levy MD2,
  3. Philippe Chollet PhD3,
  4. Yacine Merrouche PhD4,
  5. Henri Roche PhD5,
  6. Pierre Kerbrat PhD6,
  7. Pierre Fumoleau PhD7,
  8. Pierre Fargeot MD7,
  9. Pierre Clavere PhD8,
  10. Bernard Chevallier MD1,§

Article first published online: 19 OCT 2006

DOI: 10.1002/cncr.22227

Issue

Cancer

Cancer

Volume 107, Issue 11, pages 2535–2544, 1 December 2006

Additional Information

How to Cite

Veyret, C., Levy, C., Chollet, P., Merrouche, Y., Roche, H., Kerbrat, P., Fumoleau, P., Fargeot, P., Clavere, P. and Chevallier, B. (2006), Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy. Cancer, 107: 2535–2544. doi: 10.1002/cncr.22227

Author Information

  1. 1

    Department of Medical Oncology, Henri Becquerel Center, Rouen, France

  2. 2

    Department of Medical Oncology, Francois Baclesse Center, Caen, France

  3. 3

    Department of Medical Oncology, Jean Perrin Center, Clermont-Ferrand, France

  4. 4

    Department of Medical Oncology, Cancer Institute of the Loire, St-Etienne, France

  5. 5

    Department of Medical Oncology, Claudius Regaud Institute, Toulouse, France

  6. 6

    Department of Medical Oncology, Eugene Marquis Center, Rennes, France

  7. 7

    Department of Medical Oncology, Georges-Francois Leclerc Center, Dijon, France

  8. 8

    Department of Radiotherapy, Hospital Center of the University of Dupuytren, Limoges, France

  1. ‡

    Fax: (011) 33 232082501

  2. §

    Deceased.

*Department of Medical Oncology, Centre Henri Becquerel, Rue d'Amiens, 76038 Rouen Cedex 1, France

  1. †

    Presented as a poster (Abstract 506) at the 33rd Annual Meeting of the American Society of Clinical Oncology, Denver, Colorado, May 17–20, 1997.

Publication History

  1. Issue published online: 17 NOV 2006
  2. Article first published online: 19 OCT 2006
  3. Manuscript Accepted: 27 JUL 2006
  4. Manuscript Revised: 12 JUN 2006
  5. Manuscript Received: 3 APR 2006

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (164K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Céline Bourgier, Eduardo Lima Pessoa, Ariane Dunant, Steve Heymann, Marc Spielmann, Catherine Uzan, Marie-Christine Mathieu, Rodrigo Arriagada, Hugo Marsiglia, Exclusive Alternating Chemotherapy and Radiotherapy in Nonmetastatic Inflammatory Breast Cancer: 20 Years of Follow-Up, International Journal of Radiation Oncology*Biology*Physics, 2012, 82, 2, 690

    CrossRef

  2. 2
    Richard C. Cabot, Nancy Lee Harris, Jo-Anne O. Shepard, Eric S. Rosenberg, Alice M. Cort, Sally H. Ebeling, Christine C. Peters, Beth A. Overmoyer, Janie M. Lee, Melinda F. Lerwill, Case 17-2011, New England Journal of Medicine, 2011, 364, 23, 2246

    CrossRef

  3. 3
    Soumya Abrous-Anane, Alexia Savignoni, Caroline Daveau, Jean-Yves Pierga, Chantal Gautier, Fabien Reyal, Remi Dendale, François Campana, Youlia M. Kirova, Alain Fourquet, Marc A. Bollet, Management of Inflammatory Breast Cancer After Neoadjuvant Chemotherapy, International Journal of Radiation Oncology*Biology*Physics, 2011, 79, 4, 1055

    CrossRef

  4. 4
    Céline Bourgier, Felipe A. Calvo, Hugo Marsiglia, Miguel Martín, Overview of preoperative radiochemotherapy in breast cancer: past or future?, Clinical and Translational Oncology, 2011, 13, 7, 446

    CrossRef

  5. 5
    S. Abrous-Anane, A. Savignoni, C. Daveau, J.-Y. Pierga, C. Gautier, F. Reyal, R. Dendale, F. Campana, Y. Kirova, A. Fourquet, M.-A. Bollet, Traitement locorégional du cancer du sein inflammatoire après chimiothérapie néoadjuvante, Cancer/Radiothérapie, 2011, 15, 8, 654

    CrossRef

  6. 6
    Shaheenah Dawood, Biology and management of inflammatory breast cancer, Expert Review of Anticancer Therapy, 2010, 10, 2, 209

    CrossRef

  7. 7
    S. Dawood, S. D. Merajver, P. Viens, P. B. Vermeulen, S. M. Swain, T. A. Buchholz, L. Y. Dirix, P. H. Levine, A. Lucci, S. Krishnamurthy, F. M. Robertson, W. A. Woodward, W. T. Yang, N. T. Ueno, M. Cristofanilli, International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment, Annals of Oncology, 2010, 22, 3, 515

    CrossRef

  8. 8
    Audrey Mailliez, Marie Christine Baranzelli, Sylvia Giard, Luc Ceugnart, Laurence Vanlemmens, Yazid Belkacemi, Yves Marie Robin, Jacques Bonneterre, Is there a Reliable Method to Assess the Complete Pathologic Response on the Tumor after Neo-adjuvant Chemotherapy in Inflammatory Breast Cancer toward Recommendations for the Pathologic Process? Experience in 56 Patients Treated in a Single Institution, The Breast Journal, 2010, 16, 5
    Direct Link:
  9. 9
    Stephen V. Liu, Laleh Melstrom, Kathy Yao, Christy A. Russell, Stephen F. Sener, Neoadjuvant therapy for breast cancer, Journal of Surgical Oncology, 2010, 101, 4
    Direct Link:
  10. You have free access to this content10
    Sarah Sinclair, Sandra M. Swain, Primary systemic chemotherapy for inflammatory breast cancer, Cancer, 2010, 116, S11
    Direct Link:
  11. 11
    Stephen K. Gruschkus, David Lairson, J. Kay Dunn, Jan Risser, Xianglin L. Du, Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma, Cancer, 2010, 116, 22
    Direct Link:
  12. 12
    Barbara Fowble, Alison Bevan, Michael Alvarado, Michelle Melisko, Leibel and Phillips Textbook of Radiation Oncology, 2010,

    CrossRef

  13. 13
    Matthew C. Abramowitz, Tianyu Li, Monica Morrow, Elin R. Sigurdson, Penny Anderson, Nicos Nicolaou, Gary Freedman, Dermal Lymphatic Invasion and Inflammatory Breast Cancer Are Independent Predictors of Outcome After Postmastectomy Radiation, American Journal of Clinical Oncology, 2009, 32, 1, 30

    CrossRef

  14. 14
    J.-H. Chen, R. S. Mehta, O. Nalcioglu, M.-Y. Su, Inflammatory Breast Cancer After Neoadjuvant Chemotherapy: Can Magnetic Resonance Imaging Precisely Diagnose the Final Pathological Response?, Annals of Surgical Oncology, 2008, 15, 12, 3609

    CrossRef

  15. 15
    Shaheenah Dawood, Naoto T. Ueno, Massimo Cristofanilli, The Medical Treatment of Inflammatory Breast Cancer, Seminars in Oncology, 2008, 35, 1, 64

    CrossRef

  16. 16
    Hiroko Nogi, Tadashi Kobayashi, Isao Tabei, Kazumi Kawase, Yasuo Toriumi, Masafumi Suzuki, Toshiaki Morikawa, Ken Uchida, The predictive value of PgR and HER-2 for response to primary systemic chemotherapy in inflammatory breast cancer, International Journal of Clinical Oncology, 2008, 13, 4, 340

    CrossRef

  17. 17
    M Debled, N Houédé, N Madranges, C Donamaria, A Floquet, M Durand, Louis Mauriac, Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis, British Journal of Cancer, 2007, 97, 12, 1642

    CrossRef

View Full Article (HTML) Get PDF (164K)